Draw
|
Currency :
Structure Search
AG005JF1
78755-81-4 | Ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
![Chemical structure of Ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate, CAS 78755-81-4](https://api.angenesci.com/structure/2022/78755-81-4.png)
AG005JF1
SDS
COA
Add to Cart
Request For Quotation
- mg
- g
- kg
- ml
- L
无数据
无数据
- mg
- g
- kg
- ml
- L
无数据
| CAS Number | 78755-81-4 |
| Catalog Number | AG005JF1(AGN-PC-00DGAG) |
| Chemical Name | Ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate |
| EC Number | 616-650-9 |
| IUPAC Name | ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate |
| InChI | InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3 |
| InChI Key | OFBIFZUFASYYRE-UHFFFAOYSA-N |
| MDL Number | MFCD00242764 |
| Molecular Formula | C15H14FN3O3 |
| Molecular Weight | 303.2884 |
| NSC Number | 759193 |
| SMILES | FC=1C=CC2=C(C(N(CC=3N2C=NC3C(=O)OCC)C)=O)C1 |
| UNII | 40P7XK9392 |
| Synonyms | Anexate,
Flumazenil,
Flumazepil,
Lanexat,
Ro 15 1788,
Ro 15-1788,
Ro 151788,
Romazicon,
flumazenil,
78755-81-4,
Anexate,
Flumazepil,
Romazicon,
Lanexat,
Mazicon,
Ro 15-1788,
Flumazenilum,
Flumazenilo,
Flumazenilum [Latin],
Flumazenilo [Spanish],
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate,
[11C]flumazenil,
Ro 151788,
Flumazenil (Ro 15-1788),
Ro-15-1788,
UNII-40P7XK9392,
C15H14FN3O3,
CHEMBL407,
Ro15-1788,
BRN 4763661,
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate,
MLS000028850,
CHEBI:5103,
OFBIFZUFASYYRE-UHFFFAOYSA-N,
MFCD00242764,
ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate,
40P7XK9392,
4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester,
NCGC00015439-06,
SMR000058450,
RO-151788,
DSSTox_CID_3064,
DSSTox_RID_76860,
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate,
Ethyl 8-fluoro-5-methyl-5,6-dihydro-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate,
DSSTox_GSID_23064,
fumazenil,
Flumazil,
[3H]Ro15-1788,
ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate,
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate,
CAS-78755-81-4,
SR-01000075879,
Flumenazil,
Flumazenil [USAN:BAN:INN],
Roma,
[11C]flumazenil (PET ligand),
Flumazenil [USAN:USP:INN:BAN],
Romazicon (TN),
4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester,
Flumazenil authentic,
FYP,
Tocris-1328,
AC1L1FSE,
Opera_ID_1516,
Lopac-F-6300,
Biomol-NT_000285,
UPCMLD-DP137,
AC1Q33UE,
Lopac0_000506,
SCHEMBL79030,
Flumazenil (JAN/USP/INN),
MLS000759529,
MLS001076354,
MLS001424108,
BIDD:GT0766,
BPBio1_001190,
GTPL4192,
GTPL4367,
IMI061,
ZINC1464,
DTXSID2023064,
UPCMLD-DP137:001,
BDBM26263,
CTK8F9785,
KS-00000XSM,
AOB5595,
HMS2051D17,
HMS2089B15,
HMS2234F06,
HMS3261F13,
HMS3267P09,
HMS3374E10,
HMS3393D17,
HMS3657K11,
HMS3676G20,
Pharmakon1600-01505701,
AFC-3002,
BCP07573,
HY-B0009,
Flumazenil, >99% (HPLC), solid,
Tox21_110148,
Tox21_500506,
NSC759193,
PDSP1_001778,
PDSP2_001761,
s1332,
AKOS015888159,
Tox21_110148_1,
AC-6846,
AN-6313,
CCG-100968,
CS-0629,
DB01205,
LP00506,
MCULE-2830706565,
NC00218,
NSC-759193,
NCGC00015439-01,
NCGC00015439-02,
NCGC00015439-03,
NCGC00015439-04,
NCGC00015439-05,
NCGC00015439-07,
NCGC00015439-08,
NCGC00015439-09,
NCGC00015439-11,
NCGC00025116-01,
NCGC00025116-02,
NCGC00025116-03,
NCGC00025116-04,
NCGC00025116-05,
NCGC00261191-01,
AJ-08034,
AS-13923,
CPD000058450,
K393,
LS-77778,
SAM001246763,
SC-15263,
ZB000344,
SBI-0050490.P002,
AB0014201,
AB2000052,
Ro-151788000,
TL8005362,
EU-0100506,
F-145,
F0958,
FT-0630863,
ST24047162,
SW197598-2,
Ro 15-1788/000,
Ro-15-1788/000,
C07825,
D00697,
F 6300,
W-5096,
AB00572626-12,
AB00572626-13,
AB00572626_14,
AB00572626_15,
755F814,
A839484,
I01-0379,
Q-201122,
SR-01000075879-1,
SR-01000075879-3,
SR-01000075879-7,
BRD-K98769987-001-01-3,
BRD-K98769987-001-12-0,
Flumazepil;Ro 15-1788;Anexate;Lanexat;Mazicon;Roma,
Z1551429735,
Flumazenil, United States Pharmacopeia (USP) Reference Standard,
ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate.,
4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 8- fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester,
8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester,
8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, ethyl ester,
8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester,
ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0(2),]tetradeca-1(14),3,5,10,12-pentaene-5-carboxylate,
ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0;{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate,
ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaene-5-carboxylate,
ethyl 8-fluoranyl-5-methyl-6-oxidanylidene-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate,
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a] [1,4]benzodiazepine-3-carboxylate,
ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine-3-carboxylate,
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepin-3-carboxylate,
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate #,
FlumUP TD,
D02MTS,
D0D5GD,
Flumazenil [USAN:INN:BAN],
CID3373,
C15-H14-F-N3-O3,
ACN-032051,
MK-1775,
Ro 15 1788,
Flumazenil (transdermal patch formulation),
Flumazenil, 99.5% - 100MG 100mg,
A2917,
A10397,
D005442,
Flumazenil (transdermal patch formulation), Coeruleus,
2-allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(4-(4-methylpiperazin-1-yl)phenylamino)-1,2-dihydropyrazolo[3,4-d]pyrimidin-3-one,
955365-80-7,
ethyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate,
|
| Complexity | 461 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 303.102g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 22 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 0 |
| Isotope Atom Count | 0 |
| Molecular Weight | 303.293g/mol |
| Monoisotopic Mass | 303.102g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 64.4A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 1 |
GHS Hazard and Precautionary Statements
| Symbol: |  |
| Hazard Class | |
| Hazard statements | H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
Certificate of Analysis
Lot Number
Related Research Chemicals
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited